Literature DB >> 27306354

[Social medicine assessment after surgical and targeted treatment of renal cell cancer].

W Vahlensieck1, W Hoffmann2, D-H Zermann3.   

Abstract

In Germany, renal cell cancer counts for 2.5 % of all carcinomas in women and 3.5 % in men. Curative therapy ensures good chances of recovery. But there might be permanent complications like renal insufficiency, pain, incisional hernia, flank muscle relaxation, and paresis. In addition, targeted therapy is associated with several potential side effects. In both therapy groups, severe psychological problems may occur. Still employed patients with these problems must be examined by an expert to estimate the possibilities of returning to working (positive scope of work) and occupations which can not be performed anymore (negative scope of work).

Entities:  

Keywords:  Performance capacity; Renal insufficiency; Renal tumor surgery; Scope of work, negative; Scope of work, positive

Mesh:

Year:  2016        PMID: 27306354     DOI: 10.1007/s00120-016-0159-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  13 in total

1.  THE HEALING OF RAT SKIN WOUNDS.

Authors:  S M LEVENSON; E F GEEVER; L V CROWLEY; J F OATES; C W BERARD; H ROSEN
Journal:  Ann Surg       Date:  1965-02       Impact factor: 12.969

Review 2.  [Structure and process quality of inpatient urologic rehabilitation].

Authors:  W Vahlensieck; M Gäck; J Gleissner; W Hoffmann; S Liedke; U Otto; D Sauerwein; E Schindler; H Schultheis; F Sommer; R Templin; M Zellner
Journal:  Urologe A       Date:  2005-01       Impact factor: 0.639

3.  Detailed analysis of morbidity following nephrectomy for renal cell carcinoma in octogenarians.

Authors:  Julien Berger; Tarek Fardoun; Elena Brassart; Grégoire Capon; Pierre Bigot; Jean-Christophe Bernhard; Jérôme Rigaud; Jean-Jacques Patard; Aurélien Descazeaud
Journal:  J Urol       Date:  2012-07-19       Impact factor: 7.450

4.  Assessment of abdominal muscle function using the Biodex System-4. Validity and reliability in healthy volunteers and patients with giant ventral hernia.

Authors:  U Gunnarsson; M Johansson; K Strigård
Journal:  Hernia       Date:  2011-03-05       Impact factor: 4.739

5.  Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma.

Authors:  Christian Gratzke; Michael Seitz; Florian Bayrle; Boris Schlenker; Patrick J Bastian; Niko Haseke; Markus Bader; Derya Tilki; Alexander Roosen; Alexander Karl; Oliver Reich; Wael Y Khoder; Stephen Wyler; Christian G Stief; Michael Staehler; Alexander Bachmann
Journal:  BJU Int       Date:  2009-02-23       Impact factor: 5.588

6.  Effect of an elastic girdle on lung function, intra-abdominal pressure, and pain after midline laparotomy: a randomized controlled trial.

Authors:  L Clay; U Gunnarsson; K A Franklin; K Strigård
Journal:  Int J Colorectal Dis       Date:  2014-01-28       Impact factor: 2.571

7.  Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 Health Survey.

Authors:  Giacomo Novara; Silvia Secco; Maria Botteri; Vincenzo De Marco; Walter Artibani; Vincenzo Ficarra
Journal:  Eur Urol       Date:  2009-04-21       Impact factor: 20.096

Review 8.  Port-site hernias occurring after the use of bladeless radially expanding trocars.

Authors:  Edmund Chiong; Paul K Hegarty; John W Davis; Ashish M Kamat; Louis L Pisters; Surena F Matin
Journal:  Urology       Date:  2009-10-24       Impact factor: 2.649

9.  Permanent flank bulge is a consequence of flank incision for radical nephrectomy in one half of patients.

Authors:  S Chatterjee; R Nam; N Fleshner; L Klotz
Journal:  Urol Oncol       Date:  2004 Jan-Feb       Impact factor: 3.498

10.  Positioning injuries associated with robotic assisted urological surgery.

Authors:  James T Mills; Michael B Burris; Daniel J Warburton; Mark R Conaway; Noah S Schenkman; Tracey L Krupski
Journal:  J Urol       Date:  2013-03-01       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.